본문 바로가기
KERD
논문KCI 등재

대한갑상선학회 갑상선분화암 진료권고안; Part V. 소아 갑상선분화암 2024

Korean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers; Part V. Pediatric Differentiated Thyroid Cancer 2024

김정한|김선욱|박영주|이은경|이지은|이준협|이상우|박소현|이영아|김근영|나동규|정윤재|임재열|송영신|오소원|서영덕|임동준|강호철|구본석|김원웅|박준욱|유창환|우승훈|이초록|권형주|원호륜|정아리|백교림|홍채문|방지인|문정은
대한갑상선학회 (Korean Thyroid Association)|2024.05|International Journal of Thyroidology|제17권 제1호|pp. 193-207

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

RecommendationGuideline소아청소년지침PediatricThyroid cancer갑상선분화암진료권고안대한갑상선학회Korean Thyroid Association
주제분류의학일반

초록

Pediatric differentiated thyroid cancers (DTCs), mostly papillary thyroid cancer (PTC, 80-90%), are diagnosed at more advanced stages with larger tumor sizes and higher rates of locoregional and/or lung metastasis. Despite the higher recurrence rates of pediatric cancers than of adult thyroid cancers, pediatric patients demonstrate a lower mortality rate and more favorable prognosis. Considering the more advanced stage at diagnosis in pediatric patients, preoperative evaluation is crucial to determine the extent of surgery required. Furthermore, if hereditary tumor syndrome is suspected, genetic testing is required. Recommendations for pediatric DTCs focus on the surgical principles, radioiodine therapy according to the postoperative risk level, treatment and follow-up of recurrent or persistent diseases, and treatment of patients with radioiodine-refractory PTCs on the basis of genetic drivers that are unique to pediatric patients.

Abstract

Pediatric differentiated thyroid cancers (DTCs), mostly papillary thyroid cancer (PTC, 80-90%), are diagnosed at more advanced stages with larger tumor sizes and higher rates of locoregional and/or lung metastasis. Despite the higher recurrence rates of pediatric cancers than of adult thyroid cancers, pediatric patients demonstrate a lower mortality rate and more favorable prognosis. Considering the more advanced stage at diagnosis in pediatric patients, preoperative evaluation is crucial to determine the extent of surgery required. Furthermore, if hereditary tumor syndrome is suspected, genetic testing is required. Recommendations for pediatric DTCs focus on the surgical principles, radioiodine therapy according to the postoperative risk level, treatment and follow-up of recurrent or persistent diseases, and treatment of patients with radioiodine-refractory PTCs on the basis of genetic drivers that are unique to pediatric patients.

참고문헌 (87)

  1. Lee YA, "Pediatric patients with multifocal papillary thyroid cancer have higher recurrence rates than adult patients : a retrospective analysis of a large pediatric thyroid cancer cohort over 33 years", J Clin Endocrinol Metab, 100(4), pp.1619~1629 (2015)
  2. Redlich A, "Age, American Thyroid Association risk group, and response to therapy are prognostic factors in children with differentiated thyroid cancer", J Clin Endocrinol Metab, 107(1), pp.e165~e177 (2022)
  3. Rangel-Pozzo A, "Genetic landscape of papillary thyroid carcinoma and nuclear architecture : an overview comparing pediatric and adult populations", Cancers(Basel), 12(11), pp.3146~ (2020)
  4. Lee YA, "Predominant DICER1 pathogenic variants in pediatric follicular thyroid carcinomas", Thyroid, 30(8), pp.1120~1131 (2020)
  5. van de Berg DJ, "Long-term oncological outcomes of papillary thyroid cancer and follicular thyroid cancer in children : a nationwide populationbased study", Front Endocrinol(Lausanne), 13, pp.899506~ (2022)
  6. Stack BC Jr, "Consensus statement by the American Association of Clinical Endocrinology(AACE)and the American Head and Neck Society Endocrine Surgery Section(AHNS-ES)on pediatric benign and malignant thyroid surgery", Head Neck, 43(4), pp.1027~1042 (2021)
  7. Peiling Yang S, "Familial non-medullary thyroid cancer : unraveling the genetic maze", Endocr Relat Cancer, 23(12), pp.R577~R595 (2016)
  8. Schultz KAP, "DICER1 and associated conditions : identification of at-risk individuals and recommended surveillance strategies", Clin Cancer Res, 24(10), pp.2251~2261 (2018)
  9. Jonker LA, "Recommendations on surveillance for differentiated thyroid carcinoma in children with PTEN hamartoma tumor syndrome", Eur Thyroid J, 9(5), pp.234~242 (2020)
  10. Tischkowitz M, "Cancer surveillance guideline for individuals with PTEN hamartoma tumour syndrome", Eur J Hum Genet, 28(10), pp.1387~1393 (2020)
  11. Correa R, "Carney complex : an update", Eur J Endocrinol, 173(4), pp.M85~M97 (2015)
  12. Geurts JL, "Screening guidelines and recommendations for patients at high risk of developing endocrine cancers", J Surg Oncol, 121(6), pp.975~983 (2020)
  13. Francis GL, "Management guidelines for children with thyroid nodules and differentiated thyroid cancer", Thyroid, 25(7), pp.716~759 (2015)
  14. Howard SR, "Paediatric differentiated thyroid carcinoma : a UK national clinical practice consensus guideline", Endocr Relat Cancer, 29(11), pp.G1~G33 (2022)
  15. Lebbink CA, "2022 European Thyroid Association guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma", Eur Thyroid J, 11(6), pp.e220146~ (2022)
  16. Bae JS, "High prevalence of DICER1 mutations and low frequency of gene fusions in pediatric follicular-patterned tumors of the thyroid", Endocr Pathol, 32(3), pp.336~346 (2021)
  17. Martucci C, "Thyroid cancer in children : a multicenter international study highlighting clinical features and surgical outcomes of primary and secondary tumors", Front Pediatr, 10, pp.914942~ (2022)
  18. Clement SC, "Presentation and outcome of subsequent thyroid cancer among childhood cancer survivors compared to sporadic thyroid cancer : a matched national study", Eur J Endocrinol, 183(2), pp.169~180 (2020)
  19. van Santen HM, "Clinical considerations for the treatment of secondary differentiated thyroid carcinoma in childhood cancer survivors", Eur J Endocrinol, 183(3), pp.P1~P10 (2020)
  20. Haddy N, "Cardiac diseases following childhood cancer treatment : cohort study", Circulation, 133(1), pp.31~38 (2016)
  21. Dietz AC, "Risk and impact of pulmonary complications in survivors of childhood cancer : a report from the Childhood Cancer Survivor Study", Cancer, 122(23), pp.3687~3696 (2016)
  22. van Dorp W, "Recommendations for premature ovarian insufficiency surveillance for female survivors of childhood, adolescent, and young adult cancer : a report from the international late effects of childhood cancer guideline harmonization group in collaboration with the PanCareSurFup consortium", J Clin Oncol, 34(28), pp.3440~3450 (2016)
  23. Skinner R, "Recommendations for gonadotoxicity surveillance in male childhood, adolescent, and young adult cancer survivors : a report from the international late effects of childhood cancer guideline harmonization group in collaboration with the PanCareSurFup consortium", Lancet Oncol, 18(2), pp.e75~e90 (2017)
  24. Turcotte LM, "Risk, risk factors, and surveillance of subsequent malignant neoplasms in survivors of childhood cancer : a review", J Clin Oncol, 36(21), pp.2145~2152 (2018)
  25. Pasqual E, "Association between radioactive iodine treatment for pediatric and young adulthood differentiated thyroid cancer and risk of second primary malignancies", J Clin Oncol, 40(13), pp.1439~1449 (2022)
  26. Machens A, "Disease impacts more than age on operative morbidity in children with Graves' disease after total thyroidectomy", Surgery, 164(5), pp.993~997 (2018)
  27. Bal CS, "Prognostic factors in pediatric differentiated thyroid cancer patients with pulmonary metastases", J Pediatr Endocrinol Metab, 28(7-8), pp.745~751 (2015)
  28. Sugino K, "Papillary thyroid carcinoma in children and adolescents : long-term follow-up and clinical characteristics", World J Surg, 39(9), pp.2259~2265 (2015)
  29. Qu N, "Predictive factors for recurrence of differentiated thyroid cancer in patients under 21 years of age and a meta-analysis of the current literature", Tumour Biol, 37(6), pp.7797~7808 (2016)
  30. Sugino K, "Risk stratification of pediatric patients with differentiated thyroid cancer : is total thyroidectomy necessary for patients at any risk?", Thyroid, 30(4), pp.548~556 (2020)
  31. Rubinstein JC, "Lymph node ratio predicts recurrence in pediatric papillary thyroid cancer", J Pediatr Surg, 54(1), pp.129~132 (2019)
  32. Olmsted C, "Pediatric differentiated thyroid carcinoma : trends in practice and outcomes over 40 years at a single tertiary care institution", J Pediatr Endocrinol Metab, 30(10), pp.1067~1074 (2017)
  33. Baumgarten HD, "Surgical management of pediatric thyroid disease : complication rates after thyroidectomy at the Children's Hospital of Philadelphia high-volume Pediatric Thyroid Center", J Pediatr Surg, 54(10), pp.1969~1975 (2019)
  34. Spinelli C, "Cervical lymph node metastases of papillary thyroid carcinoma, in the central and lateral compartments, in children and adolescents : predictive factors", World J Surg, 42(8), pp.2444~2453 (2018)
  35. Propst EJ, "Patterns and predictors of metastatic spread to the neck in pediatric thyroid carcinoma", Laryngoscope, 131(3), pp.E1002~E1009 (2021)
  36. Tuggle CT, "Pediatric endocrine surgery : who is operating on our children?", Surgery, 144(6), pp.869~877 (2008)
  37. Kao KT, "Risk factors for the development of hypocalcemia in pediatric patients after total thyroidectomy-a systematic review", Int J Pediatr Otorhinolaryngol, 143, pp.110666~ (2021)
  38. Lorenz K, "Volume, outcomes, and quality standards in thyroid surgery : an evidence-based analysis-European Society of Endocrine Surgeons(ESES)positional statement", Langenbecks Arch Surg, 405(4), pp.401~425 (2020)
  39. Back K, "Optimal value of lymph node ratio and metastatic lymph node size to predict risk of recurrence in pediatric thyroid cancer with lateral neck metastasis", J Pediatr Surg, 58(3), pp.568~573 (2023)
  40. Gui Y, "Predictive factors for recurrence of papillary thyroid carcinoma in children and adolescents", Front Oncol, 12, pp.833775~ (2022)
  41. Zanella A, "Role of postoperative stimulated thyroglobulin as prognostic factor for differentiated thyroid cancer in children and adolescents", Thyroid, 27(6), pp.787~792 (2017)
  42. Karapanou O, "Long-term outcome of differentiated thyroid cancer in children and young adults : risk stratification by ATA criteria and assessment of pre-ablation stimulated thyroglobulin as predictors of disease persistence", Endocrine, 70(3), pp.566~574 (2020)
  43. Lazar L, "Pediatric thyroid cancer : postoperative classifications and response to initial therapy as prognostic factors", J Clin Endocrinol Metab, 101(5), pp.1970~1979 (2016)
  44. Pires BP, "Prognostic factors for early and long-term remission in pediatric differentiated thyroid carcinoma : the role of sex, age, clinical presentation, and the newly proposed American Thyroid Association risk stratification system", Thyroid, 26(10), pp.1480~1487 (2016)
  45. Sung TY, "Initial and dynamic risk stratification of pediatric patients with differentiated thyroid cancer", J Clin Endocrinol Metab, 102(3), pp.793~800 (2017)
  46. Zanella AB, "Dynamic risk stratification in the follow-up of children and adolescents with differentiated thyroid cancer", Thyroid, 28(10), pp.1285~1292 (2018)
  47. Majeed AK, "Dynamic risk stratification for predicting long-term outcomes in pediatric differentiated thyroid cancers", J Clin Endocrinol Metab, 108(6), pp.e208~e215 (2023)
  48. Padovani RP, "Even without additional therapy, serum thyroglobulin concentrations often decline for years after total thyroidectomy and radioactive remnant ablation in patients with differentiated thyroid cancer", Thyroid, 22(8), pp.778~783 (2012)
  49. Dekker BL, "Bone mineral density in adult survivors of pediatric differentiated thyroid carcinoma : a longitudinal follow-up study", Thyroid, 31(11), pp.1707~1714 (2021)
  50. Chow SM, "Differentiated thyroid carcinoma in childhood and adolescence-clinical course and role of radioiodine", Pediatr Blood Cancer, 42(2), pp.176~183 (2004)
  51. Jarzab B, "Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment : a qualitative review", Endocr Relat Cancer, 12(4), pp.773~803 (2005)
  52. Handkiewicz-Junak D, "Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer", J Nucl Med, 48(6), pp.879~888 (2007)
  53. Newman KD, "Differentiated thyroid cancer : determinants of disease progression in patients <21 years of age at diagnosis : a report from the Surgical Discipline Committee of the Children's Cancer Group", Ann Surg, 227(4), pp.533~541 (1998)
  54. Haymart MR, "Disease severity and radioactive iodine use for thyroid cancer", J Clin Endocrinol Metab, 98(2), pp.678~686 (2013)
  55. Van Nostrand D, "Radioiodine in the treatment of thyroid cancer", Endocrinol Metab Clin North Am, 36(3), pp.807~822 (2007)
  56. Reiners C, "Twenty-five years after Chernobyl : outcome of radioiodine treatment in children and adolescents with very high-risk radiation-induced differentiated thyroid carcinoma", J Clin Endocrinol Metab, 98(7), pp.3039~3048 (2013)
  57. Verburg FA, "I-131 activities as high as safely administrable(AHASA)for the treatment of children and adolescents with advanced differentiated thyroid cancer", J Clin Endocrinol Metab, 96(8), pp.E1268~E1271 (2011)
  58. Sgouros G, "Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry(3D-ID)software", J Nucl Med, 45(8), pp.1366~1372 (2004)
  59. Jentzen W, "Optimized 124I PET dosimetry protocol for radioiodine therapy of differentiated thyroid cancer", J Nucl Med, 49(6), pp.1017~1023 (2008)
  60. Pettinato C, "Usefulness of 124I PET", CT imaging to predict absorbed doses in patients affected by metastatic thyroid cancer and treated with 131I, 2012, pp.56(6), 509~514
  61. Iorcansky S, "Serum thyrotropin(TSH)levels after recombinant human TSH injections in children and teenagers with papillary thyroid cancer", J Clin Endocrinol Metab, 90(12), pp.6553~6555 (2005)
  62. Rosario PW, "Recombinant human TSH for thyroid remnant ablation with(131)I in children and adolescents with papillary carcinoma", Horm Res Paediatr, 77(1), pp.59~62 (2012)
  63. Hoe FM, "Use of the recombinant human TSH stimulated thyroglobulin level and diagnostic whole body scan in children with differentiated thyroid carcinoma", J Pediatr Endocrinol Metab, 19(1), pp.25~30 (2006)
  64. Schumm MA, "Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal preparation for radioiodine ablation in differentiated thyroid cancer in children, adolescents and young adults", Clin Endocrinol(Oxf), 95(2), pp.344~353 (2021)
  65. Hall P, "Cancer risks in thyroid cancer patients", Br J Cancer, 64(1), pp.159~163 (1991)
  66. Travis CC, "131I ablation treatment in young females after the Chernobyl accident", J Nucl Med, 47(10), pp.1723~1727 (2006)
  67. Seo GH, "radioactive iodine treatment for children and young adults with thyroid cancer in South Korea : a population-based study", J Clin Endocrinol Metab, 106(7), pp.e2580~e2588 (2021)
  68. Canale D, "Effects of radioiodine treatment for differentiated thyroid cancer on testis function", Clin Endocrinol(Oxf), 82(2), pp.295~299 (2015)
  69. Hyer S, "Testicular dose and fertility in men following I(131)therapy for thyroid cancer", Clin Endocrinol(Oxf), 56(6), pp.755~758 (2002)
  70. Bourcigaux N, "Impact on testicular function of a single ablative activity of 3. 7 GBq radioactive iodine for differentiated thyroid carcinoma", Hum Reprod, 33(8), pp.1408~1416 (2018)
  71. Lushbaugh CC, "The effects of gonadal irradiation in clinical radiation therapy : a review", Cancer, 37(2 Suppl), pp.1111~1125 (1976)
  72. Sarkar SD, "Subsequent fertility and birth histories of children and adolescents treated with 131I for thyroid cancer", J Nucl Med, 17(6), pp.460~464 (1976)
  73. Nies M, "Long-term male fertility after treatment with radioactive iodine for differentiated thyroid carcinoma", Eur J Endocrinol, 185(6), pp.775~782 (2021)
  74. Sioka C, "Effects of I-131 therapy on gonads and pregnancy outcome in patients with thyroid cancer", Fertil Steril, 95(5), pp.1552~1559 (2011)
  75. Yaish I, "A single radioactive iodine treatment has a deleterious effect on ovarian reserve in women with thyroid cancer : results of a prospective pilot study", Thyroid, 28(4), pp.522~527 (2018)
  76. Acibucu F, "Evaluation of ovarian reserve with AMH level in patients with well-differentiated thyroid cancer receiving radioactive iodine ablation treatment", Exp Clin Endocrinol Diabetes, 124(10), pp.593~596 (2016)
  77. Giusti M, "Anti-Mullerian hormone in pre-menopausal females after ablative radioiodine treatment for differentiated thyroid cancer", Endocrine, 60(3), pp.516~523 (2018)
  78. Nies M, "Long-term effects of radioiodine treatment on female fertility in survivors of childhood differentiated thyroid carcinoma", Thyroid, 30(8), pp.1169~1176 (2020)
  79. Yan L, "Radiofrequency ablation for cervical metastatic lymph nodes in children and adolescents with papillary thyroid carcinoma : a preliminary study", Front Endocrinol(Lausanne), 12, pp.624054~ (2021)
  80. Pawelczak M, "Outcomes of children and adolescents with well-differentiated thyroid carcinoma and pulmonary metastases following 131I treatment : a systematic review", Thyroid, 20(10), pp.1095~1101 (2010)
  81. Nies M, "Distant metastases from childhood differentiated thyroid carcinoma : clinical course and mutational landscape", J Clin Endocrinol Metab, 106(4), pp.e1683~e1697 (2021)
  82. Hebestreit H, "Pulmonary fibrosis in youth treated with radioiodine for juvenile thyroid cancer and lung metastases after Chernobyl", Eur J Nucl Med Mol Imaging, 38(9), pp.1683~1690 (2011)
  83. Lee YA, "NTRK and RET fusion-directed therapy in pediatric thyroid cancer yields a tumor response and radioiodine uptake", J Clin Invest, 131(18), pp.e133847~ (2021)
  84. Franco AT, "Fusion oncogenes are associated with increased metastatic capacity and persistent disease in pediatric thyroid cancers", J Clin Oncol, 40(10), pp.1081~1090 (2022)
  85. Papini E, "Risk of malignancy in nonpalpable thyroid nodules : predictive value of ultrasound and color-Doppler features", J Clin Endocrinol Metab, 87(5), pp.1941~1946 (2002)
  86. Cherella CE, "Pediatric thyroid cancer : recent developments", Best Pract Res Clin Endocrinol Metab, 37(1), pp.101715~ (2023)
  87. Waguespack SG, "Larotrectinib before initial radioactive iodine therapy in pediatric TRK fusion-positive papillary thyroid carcinoma : time to reconsider the treatment paradigm for distantly metastatic disease?", JCO Precis Oncol, 6, pp.e2100467~ (2022)

관련 논문AI추천

소아청소년 갑상선 분화암의 치료 결과강명구, 박헌수, 이동근, 홍종철대한이비인후과학회 · 대한이비인후과학회지 두경부외과학2012 · 제55권 제7호대한갑상선학회 갑상선분화암 진료권고안; 개요 및 요약 2024강호철, 구본석, 권형주, 김근영, 김미진, 김보현, 김선욱, 김원구, 김원배, 김원웅, 김정한, 김희경, 나동규, 나희영, 문신제, 문정은, 박도준, 박소현, 박영주, 박준욱, 방지인, 백교림, 서영덕, 송영신, 신동엽, 신수진, 안화영, 오소원, 우승훈, 원호륜, 유창환, 윤지희, 이가희, 이민경, 이상우, 이승은, 이시훈, 이영아, 이은경, 이준협, 이지예, 이지은, 이초록, 임동준, 임재열, 전윤경, 정경연, 정아리, 정웅윤, 정윤재, 정찬권, 조관훈, 조윤영, 홍아람, 홍채문대한갑상선학회 · International Journal of Thyroidology2024 · 제17권 제1호Clinical characteristics, risk stratifications, and long-term follow-up of childhood differentiated thyroid cancer: a single-center experienceAycan Zehra, Bahadır Gülnur Göllü, Berberoğlu Merih, Çetin Sirmen Kızılcan, Ceyhan Koray, Fitöz Suat, Kır Metin, Özsu Elif, Şıklar Zeynep, Soydal Çiğdem, Taşyıldız Nurdan, Ünal Emel, Yağmurlu Aydın대한소아내분비학회 · Annals of Pediatric Endocrinology & Metabolism2025 · 제30권 제2호Recurrent Thyroid Papillary Carcinoma in Children Under Ten Years Old: Report of Two Cases and Literature Review김윤화, 노병주, 박용구, 성지윤대한병리학회 · Journal of Pathology and Translational Medicine2014 · 제48권 제4호대한갑상선학회 갑상선분화암 진료권고안 2024 어떻게 바뀌었나: 진단부터 초기치료까지이은경대한갑상선학회 · International Journal of Thyroidology2024 · 제17권 제2호대한갑상선학회 갑상선분화암 진료권고안; Part II. 갑상선분화암의 추적 2024강호철, 김미진, 김보현, 김선욱, 나동규, 박영주, 방지인, 서영덕, 송영신, 오소원, 이민경, 이상우, 이은경, 이지예, 임동준, 정아리, 정윤재, 홍채문대한갑상선학회 · International Journal of Thyroidology2024 · 제17권 제1호

이 간행물의 다른 논문 (16건)

대한갑상선학회 갑상선분화암 진료권고안; 개요 및 요약 2024조윤영, 이승은, 박소현, 이상우, 이준협, 이지예, 이지은, 김희경, 이은경, 이민경, 김미진, 김선욱, 김정한, 정경연, 강호철, 임동준, 서영덕, 김원구, 이시훈, 문정은, 신수진, 김원배, 윤지희, 오소원, 송영신, 이가희, 임재열, 전윤경, 신동엽, 정윤재, 나동규, 김근영, 이영아, 김보현, 방지인, 조관훈, 박영주, 홍채문, 문신제, 홍아람, 백교림, 정웅윤, 정아리, 원호륜, 권형주, 나희영, 이초록, 우승훈, 박도준, 유창환, 정찬권, 박준욱, 김원웅, 구본석, 안화영pp. 1-20대한갑상선학회 갑상선분화암 진료권고안; Part I. 갑상선분화암의 초기치료 - 제1장 갑상선분화암의 수술 전 병기를 예측하기 위한 영상 및 혈액 검사 2024김선욱, 이민경, 박영주, 이은경, 이상우, 나동규, 정윤재, 송영신, 임동준, 강호철, 이지예, 조관훈, 방지인pp. 21-29대한갑상선학회 갑상선분화암 진료권고안; Part I. 갑상선분화암의 초기치료 - 제2장 갑상선분화암의 적절한 초기 수술 2024조윤영, 김정한, 김선욱, 이민경, 박영주, 이은경, 김희경, 이지예, 이준협, 나동규, 정윤재, 임재열, 송영신, 윤지희, 임동준, 강호철, 구본석, 김원웅, 박준욱, 정찬권, 유창환, 우승훈, 이초록, 권형주, 원호륜, 백교림pp. 30-52대한갑상선학회 갑상선분화암 진료권고안; Part I. 갑상선분화암의 초기치료 - 제3장 갑상선분화암의 수술 전후 합병증 평가 2024김선욱, 박영주, 이시훈, 유창환, 홍아람, 원호륜, 우승훈, 박준욱, 구본석, 강호철, 임동준, 이은경, 나동규, 정윤재, 전윤경, 임재열, 송영신pp. 53-60대한갑상선학회 갑상선분화암 진료권고안; Part I. 갑상선분화암의 초기치료 - 제4장 갑상선분화암의 수술 후 병리학적 진단 및 병기 결정 2024김선욱, 신수진, 나희영, 정찬권, 강호철, 임동준, 송영신, 정윤재, 나동규, 이은경, 박영주pp. 61-67
원문 보기